Conexeu Sciences Inc.

NASDAQ: CNXU · Healthcare · Biotechnology

PublicHQ Reno, NV · WashoeCIK 0002066836Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 27

v0.1 · 5/100 weight · pillars only

↑ market scale, filing timeliness · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-09-02

Market cap

$157.1M

as of 2026-09-02

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Conexeu Sciences Inc.’s financial profile?

Conexeu Sciences Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Neumora Therapeutics, Inc. Common Stock——NervGen Pharma Corp. Common stock——Canton Strategic Holdings Inc——Immunic, Inc.——Organigram Global Inc.——Tenaya Therapeutics, Inc.——

Neighbors

Washoe →

U-Haul Holding Company$761.5M60C Figure Technology Solutions, Inc. Class A Common Stock$506.9M45D Ormat Technologies, Inc.$989.5M64C Caesars Entertainment, Inc.$11.5B57C Monarch Casino & Resort, Inc.$545.1M66B i-80 Gold Corp.$95.2M37D

Key facts

CEOMiles Harrison

SectorHealthcare

IndustryBiotechnology

HeadquartersReno, NV

ExchangeNASDAQ: CNXU

Employees4

IPO date2026-05-21

Latest filings

10-Q2026-09-14 8-K2026-09-10 8-K2026-07-07 10-Q2026-06-15 8-K2026-06-09 8-K2026-05-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.